# US 2011/0211161 A1 · Diagnostic, Prescriptive, And Data-Gathering System And Method For Macular Pigment Deficits And Other Eye Disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0211161 A1
- Document ID: US20110211161A1
- Status: Published application
- Kind: A1
- Application number: 13/087,005
- Filed: 2011-04-14
- Published: 2011-09-01
- Earliest claimed: 2006-01-23
- Assignees: ZeaVision LLC
- Inventors: Dennis L. Gierhart; Terry B. Hatfield
- Web page: https://patentgrep.com/patent/US20110211161A1

## CPC

- G16H 70/20: relating to practices or guidelines
- A61B 3/0025: {characterised by electronic signal processing, e.g. eye models}
- A61B 3/10: Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B 3/12: for looking at the eye fundus, e.g. ophthalmoscopes (A61B3/13 takes precedence)
- A61B 3/14: Arrangements specially adapted for eye photography
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 20/60: relating to nutrition control, e.g. diets
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G16Z 99/00: Subject matter not provided for in other main groups of this subclass
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16Z: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR

## Abstract

A macular health measurement and storage system comprises a plurality of macular-pigment measurement machine for measuring macular pigment density in humans, a plurality of computers each of which is associated with a corresponding one the macular-pigment measuring machines, and a central host. The plurality of macular-pigment measurement machines include a device for receiving macular pigment data from a patient, at least one data transfer port, and at least one processor that enables the transfer of the macular pigment data from the transfer port. The plurality of computers include a first port coupled to the data transfer port of the corresponding macular-pigment measurement machine for receiving the macular pigment data. Each of the computers includes a second port for transferring patient data. The central host is coupled to the second ports on each of the plurality of computers. The central host includes a storage device for storing the patient data.

## Claims

### Claim at position 1

1-74. (canceled)

### Claim 75

An eye health measurement and storage system, comprising:
a plurality of macular-pigment measurement machines for measuring macular pigment density in humans, each of said macular-pigment measuring machines receiving macular pigment data from a patient, each of said macular-pigment measuring machines including at least one data transfer port and at least one processor for enabling the transfer of said macular pigment data from said transfer port to a computer in communication therewith; and
a central host remotely located from and coupled to said plurality of macular-pigment measurement machines, said central host including a storage device for storing patient information and said macular pigment data for future use by said patient, said patient information including at least three of the group consisting of eye color, age, gender, smoking status, previously diagnosed eye disease, intake of nutritional supplements, genetic information, and diet; and
wherein said patient information and said macular pigment data are used to calculate a risk assessment indication for determining the likelihood of said patient being inflicted with macular degeneration, said risk assessment indication being used to provide a recommendation for said patient of a first carotenoid mixture or a second carotenoid mixture, said second carotenoid mixture being different from said first carotenoid mixture.

### Claim 76 (depends on 75)

The system of claim 75, wherein said central host includes a website that has been designed to receive said patient data.

### Claim 77 (depends on 75)

The system of claim 75, further in combination with said computer, said computer including an input device for receiving said patient information.

### Claim 78 (depends on 77)

The system of claim 77, wherein said patient uses said computer to enter said patient information.

### Claim 79 (depends on 77)

The system of claim 77, wherein each of said computers includes a storage device for storing said macular pigment data for each of said patients.

### Claim 80 (depends on 77)

The system of claim 77, wherein said central host stores said patient information and said macular pigment data transferred from each of said computers in a central storage device.

### Claim 81 (depends on 75)

The system of claim 75, wherein said macular-pigment measurement machines are designed to measure at least one additional physiological or macular-function indicator of eye health or vision status and data from said at least one physiological or macular-function indicator is received by said central host.

### Claim 82 (depends on 75)

The system of claim 75, wherein the three types of said patient information include age, gender, and genetic information.

### Claim 83 (depends on 75)

The system of claim 75, wherein each of said plurality of macular-pigment measurement machines is one of a group consisting of a scanning laser opthalmoscope, a reflectometry device, a flicker photometry device, autofluorescence device, a Raman-scattering device, an anomalscope, and a modified fundas camera.

### Claim 84 (depends on 75)

The system of claim 75, wherein said first carotenoid mixture includes a first amount of zeaxanthin and said second carotenoid mixture includes a second amount of zeaxanthin that is different from said first amount of zeaxanthin.

### Claim 85

A method of addressing eye-health problems in a human patient, comprising the acts of:
receiving information from multiple patients at multiple locations, said information for each patient including macular pigment data obtained via a macular-pigment measurement machine at one of said locations, each of said macular-pigment measurement machines being linked to a central host, said information for each patient further including at least three of the group consisting of eye color, age, gender, smoking status, previously diagnosed eye disease, intake of nutritional supplements, genetic information, and diet;
in response to the patient having a first level of macular pigment, providing the patient with a recommendation for a first carotenoid mixture to increase said macular pigment of the patient to a desirable level over a period of time;
in response to the patient having a second level of macular pigment, providing the patient with a recommendation for a second carotenoid mixture that is different from said first carotenoid mixture; and
periodically transferring, by use of a processor, said information to said central host from said plurality of locations.

### Claim 86 (depends on 85)

The method of claim 85, further including using statistical analyses to evaluate correlations between macular pigment density and said first and second carotenoid mixtures.

### Claim 87 (depends on 86)

The method of claim 86, wherein said statistical analyses correlates macular pigment density to patients who are not taking said first and second carotenoid mixtures.

### Claim 88 (depends on 86)

The method of claim 86, wherein said statistical analyses correlates macular pigment density to one or more of said eye color, age, gender, smoking status, previously diagnosed eye disease, intake of nutritional supplements, genetic information, and diet.

### Claim 89 (depends on 86)

The method of claim 86, wherein said providing of said first carotenoid mixture and said providing of said second carotenoid mixture to a particular patient is further in response to conclusions supported by said statistical analyses, said conclusions relating to a characteristic of said particular patient.

### Claim 90 (depends on 89)

The method of claim 89, wherein said characteristic includes at least one of the group consisting of eye color, age, gender, smoking status, previously diagnosed eye disease, genetic information, and diet.

### Claim 91 (depends on 85)

The system of claim 85, wherein said macular pigment data and said patient information are associated with an anonymous patient identification.

### Claim 92 (depends on 85)

The method of claim 85, wherein each of said macular-pigment measurement machines is coupled to a computer, said periodic transferring of said information to said central host occurring via said computers.

### Claim 93 (depends on 92)

The method of claim 92, wherein said computers are used for entering said information related to eye color, age, gender, smoking status, previously diagnosed eye disease, intake of nutritional supplements, genetic information, or diet.

### Claim 94 (depends on 85)

The method of claim 85, wherein each of said plurality of macular-pigment measurement machines is one of a group consisting of a scanning laser opthalmoscope, a reflectometry device, a flicker photometry device, autofluorescence device, a Raman-scattering device, an anomalscope, and a modified fundas camera.

### Claim 95

A method of addressing eye-health problems in a human patient, comprising the acts of:
receiving information from multiple patients at multiple locations, said information for each patient including macular pigment data obtained via a macular-pigment measurement machine at one of said locations, said macular-pigment measurement machines being linked to a central host, said information for each patient further including at least three of the group consisting of eye color, age, gender, smoking status, previously diagnosed eye disease, intake of nutritional supplements, genetic information, and diet;
periodically transferring said information from said patients at said central host from said plurality of locations;
in response to a patient having a first level of macular pigment as measured by one of said macular-pigment measurement machines, providing the patient with a recommendation for a first carotenoid mixture to increase said macular pigment of the patient, said recommendation for said first carotenoid mixture being based on data related to said information that is received at said central host; and
in response to the patient having a second level of macular pigment as measured by the one of said macular-pigment measurement machines, providing the patient with a recommendation for a second carotenoid mixture to increase said macular pigment of the patient, said second carotenoid mixture being different from said first carotenoid mixture, said recommendation for said second carotenoid mixture being based on data related to said information that is received at said central host.

### Claim 96 (depends on 95)

The method of claim 95, wherein each of said macular-pigment measurement machines is coupled to a computer, said periodic transferring of said information to said central host occurring via said computers.

### Claim 97 (depends on 95)

The method of claim 95, further including conducting, with a processor at said central host, statistical analysis on said information, said data used for said recommendations for said first and second carotenoid mixtures being based on said statistical analysis.

### Claim 98 (depends on 95)

The method of claim 95, wherein said first carotenoid mixture includes a first amount of zeaxanthin and said second carotenoid mixture includes a second amount of zeaxanthin that is different from said first amount of zeaxanthin.
